MasterPharm Recalls Progesterone Tablets Due to Processing Control Deficiencies
MasterPharm LLC is recalling specific lots of Progesterone 150 mg tablets because they lack assurance of conformity to specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of processing controls without reported injuries or illnesses, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
MasterPharm LLC is voluntarily recalling specific lots of Progesterone (Rapid-Dissolve) 150 mg tablets. The recall was initiated due to a lack of processing controls, which means there is no assurance that the product conforms to required specifications.
The affected product is distributed nationwide in the United States. The specific lots involved are identified by the codes 02-13-2020:83@8 (Best Use Date 8/11/2020) and 02-14-2020:64@11 (Best Use Date 8/12/2020). Each bottle contains 30 tablets.
Consumers who have these specific lots of the medication should stop using them and contact their healthcare provider or pharmacist for guidance. The recalling firm, MasterPharm LLC, can be reached at (866) 630-5600 for further information.
The recalled product
- Product
- Progesterone (Rapid-Dissolve) 150 mg Tablet, 30 tablets per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
- Manufacturer
- MasterPharm LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 288
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- 02-13-2020:83@8
- BUD 8/11/2020 02-14-2020:64@11
- BUD 8/12/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 26 recalled by MasterPharm LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · MasterPharm LLC
See all →- ModerateMasterPharm Recalls Tadalafil 12 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Formula 82M Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
Same hazard · quality control
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateDuoGlide Short-Term Dialysis Catheter recall due to deficient manufacturing
FDA (Devices) · 2026-07-08
- ModeratedirectCHECK whole blood control labeled with incorrect performance range
FDA (Devices) · 2026-06-24
- HighAmyloid plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11